Open Access Open Access  Restricted Access Subscription Access

A Concise Report on the Pathophysiology of Heart Failure

Sony Sharlet E, Guruprasad M., Muralinath E., Mohan Naidu K., Srinivas Prasad, Jayinder Paul Singh G., Panjan Ghosh. P., Kalyan C., Archana Jain

Abstract


Heart failure remains a significant health challenge globally, influencing millions of individuals and imposing a considerable burden on healthcare systems. Factors influencing heart failure include Cardiac remodeling, neuro hormonal activation, impaired contractility as well as ejection fraction, ventricular dysfunction as well as chamber dilation, inflammatory as well as oxidative stress, endothelial dysfunction and microbial dysfunction. Finally it is concluded that heart failure is a complex syndrome resulting from multiple pathophysiological mechanisms.


Full Text:

PDF

References


Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., ... & Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 79(17), e263-e421.

Ziaeian, B., & Fonarow, G. C. (2016). Epidemiology and aetiology of heart failure. Nature Reviews Cardiology, 13(6), 368-378.

Swedberg, K., Kjekshus, J., & CONSENSUS Trial Study Group. (1988). Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The American journal of cardiology, 62(2), 60A-66A.

Lind, L., Ingelsson, M., Sundstrom, J., & Ärnlöv, J. (2021). Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings. Open heart, 8(2), e001735.

Noubiap, J. J., Agbor, V. N., Bigna, J. J., Kaze, A. D., Nyaga, U. F., & Mayosi, B. M. (2019). Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies. Scientific reports, 9(1), 17022.

Kim, K. H., & Pereira, N. L. (2021). Genetics of cardiomyopathy: clinical and mechanistic implications for heart failure. Korean Circulation Journal, 51(10), 797.

Rezkalla, S. H., & Kloner, R. A. (2021). Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics. Trends in cardiovascular medicine, 31(3), 163-169.

Muchtar, E., Blauwet, L. A., & Gertz, M. A. (2017). Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circulation research, 121(7), 819-837.

Shams, P., & Ahmed, I. (2023). Cardiac amyloidosis. In StatPearls [Internet]. StatPearls Publishing.

Shams, P., & Ahmed, I. (2023). Cardiac amyloidosis. In StatPearls [Internet]. StatPearls Publishing.

Matta, A. G., & Carrié, D. (2023). Epidemiology, pathophysiology, diagnosis, and principles of management of Takotsubo cardiomyopathy: a review. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 29, e939020-1.

Bairashevskaia, A. V., Belogubova, S. Y., Kondratiuk, M. R., Rudnova, D. S., Sologova, S. S., Tereshkina, O. I., & Avakyan, E. I. (2022). Update of Takotsubo cardiomyopathy: Present experience and outlook for the future. IJC Heart & Vasculature, 39, 100990.

Malik, A., Brito, D., Vaqar, S., Chhabra, L., & Doerr, C. (2023). Congestive heart failure (nursing). In StatPearls [internet]. StatPearls Publishing.

DeFilippis, E. M., Beale, A., Martyn, T., Agarwal, A., Elkayam, U., Lam, C. S., & Hsich, E. (2022). Heart failure subtypes and cardiomyopathies in women. Circulation research, 130(4), 436-454.

Wong, C. M., Hawkins, N. M., Jhund, P. S., MacDonald, M. R., Solomon, S. D., Granger, C. B., ... & McMurray, J. J. (2013). Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). Journal of the American College of Cardiology, 62(20), 1845-1854.

Sciomer, S., Moscucci, F., Salvioni, E., Marchese, G., Bussotti, M., Corrà, U., & Piepoli, M. F. (2020). Role of gender, age and BMI in prognosis of heart failure. European journal of preventive cardiology, 27(2_suppl), 46-51.

Volpe, M., & Gallo, G. (2023). Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC). Frontiers in Cardiovascular Medicine, 10, 1136340.

Kim, S. H., & Ryu, K. H. (2019). Tachycardia induced cardiomyopathy. Korean circulation journal, 49(9), 808.

Anakwue, R. C., Onwubere, B. J. C., Anisiuba, B. C., Ikeh, V. O., Mbah, A., & Ike, S. O. (2010). Congestive heart failure in subjects with thyrotoxicosis in a black community. Vascular health and risk management, 473-477.

Schoenenberger, A. W., Schoenenberger-Berzins, R., Der Maur, C. A., Suter, P. M., Vergopoulos, A., & Erne, P. (2012). Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clinical research in cardiology, 101, 159-164.

DiNicolantonio, J. J., Liu, J., & O'Keefe, J. H. (2018). Thiamine and cardiovascular disease: a literature review. Progress in cardiovascular diseases, 61(1), 27-32.

Reddy, Y. N., Melenovsky, V., Redfield, M. M., Nishimura, R. A., & Borlaug, B. A. (2016). High-output heart failure: a 15-year experience. Journal of the American College of Cardiology, 68(5), 473-482.

Chayanupatkul, M., & Liangpunsakul, S. (2014). Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatology international, 8, 308-315.

Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., ... & American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. (2020). Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation, 141(9), e139-e596.

Ho, K. K., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993). The epidemiology of heart failure: the Framingham Study. Journal of the American College of Cardiology, 22(4), A6-A13.

Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., ... & Muntner, P. (2017). Heart disease and stroke statistics—2017 update: a report from the American Heart Association. circulation, 135(10), e146-e603.

Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P., ... & Dagenais, G. (2020). Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet, 395(10226), 795-808.

Opie, L. H., Commerford, P. J., Gersh, B. J., & Pfeffer, M. A. (2006). Controversies in ventricular remodelling. The Lancet, 367(9507), 356-367.

Kemp, C. D., & Conte, J. V. (2012). The pathophysiology of heart failure. Cardiovascular Pathology, 21(5), 365-371.

Mou, Y. A., Bollensdorff, C., Cazorla, O., Magdi, Y., & de Tombe, P. P. (2015). Exploring cardiac biophysical properties. Global Cardiology Science and Practice, 2015(1), 10.

Abassi, Z., Khoury, E. E., Karram, T., & Aronson, D. (2022). Edema formation in congestive heart failure and the underlying mechanisms. Frontiers in cardiovascular medicine, 9, 933215.

Prausmüller, S., Arfsten, H., Spinka, G., Freitag, C., Bartko, P. E., Goliasch, G., ... & Hülsmann, M. (2020). Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HF r EF. Journal of the American Heart Association, 9(11), e015071.


Refbacks

  • There are currently no refbacks.